The partnership pairs Novo Nordisk’s expertise in protein therapeutics with Vivtex’s gastrointestinal screening and formulation platform.

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

If you missed our video discussion on AGBT day one, view it here. Don’t miss Julianna LeMieux’s GEN Live on March 2. We deliver a full debrief on the news from AGBT—critical to understanding where NGS ...

ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...

Researchers say study identifies location of oligodendrocytes in the brain, and integrates information about gene expression and the structural features of neurons.

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, ...

Beam is advancing BEAM-304 using an approach in which multiple mutation-specific base editors are developed within a single clinical program.

The Taylor vortex fermenter-extractor-separator is designed for small volume, value-added cellular products and process intensification.

The study also highlights the limitations of relying on body mass index (BMI) as a proxy for metabolic health.

In this GEN webinar, experts from ChemPartner, Philip Clarke, PhD, Hu Liu, PhD, and Greg Liang, MD, will provide an overview of some of the innovative platforms that are shaping the next-generation of ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...